{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:40:20Z","timestamp":1790962820996,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T00:00:00Z","timestamp":1602374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T00:00:00Z","timestamp":1602374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Related research has recognized the vital role of methionine cycle metabolism in cancers. However, the role and mechanism of methionine cycle metabolism in hepatocellular carcinoma are still unknown. In this study, we found that [Cu(ttpy-tpp)Br<jats:sub>2<\/jats:sub>]Br (Referred to as CTB) could induce hepatocellular carcinoma cells senescence, which is a new copper complex synthesized by our research group. Interestingly, CTB induces senescence by inhibiting the methionine cycle metabolism of HCC cells. Furthermore, the inhibitory effect of CTB on the methionine cycle depends on mitochondrial carrier protein SLC25A26, which was also required for CTB-induced HCC cells senescence. Importantly, we found that CTB-induced upregulation of SLC25A26 could cause abnormal methylation of TERT and inhibited TERT expression, which is considered to be an essential cause of cell senescence. The same results were also obtained in vivo, CTB inhibits the growth of subcutaneously implanted tumors in nude mice and promoted the expression of senescence markers in tumor tissues, and interference with SLC25A26 partially offset the antitumor effect of CTB.<\/jats:p>","DOI":"10.1038\/s41419-020-03048-x","type":"journal-article","created":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T10:02:24Z","timestamp":1602410544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Novel copper complex CTB regulates methionine cycle induced TERT hypomethylation to promote HCC cells senescence via mitochondrial SLC25A26"],"prefix":"10.1038","volume":"11","author":[{"given":"Chun","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-9773","authenticated-orcid":false,"given":"Xiaoyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangjuan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,11]]},"reference":[{"key":"3048_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12072-018-9919-1","volume":"13","author":"T Couri","year":"2019","unstructured":"Couri, T. & Pillai, A. Goals and targets for personalized therapy for HCC. Hepatol. Int. 13, 125\u2013137 (2019).","journal-title":"Hepatol. Int."},{"key":"3048_CR2","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jhep.2019.09.010","volume":"72","author":"S Faivre","year":"2020","unstructured":"Faivre, S., Rimassa, L. & Finn, R. S. Molecular therapies for HCC: Looking outside the box. J. Hepatol. 72, 342\u2013352 (2020).","journal-title":"J. Hepatol."},{"key":"3048_CR3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/med.21455","volume":"38","author":"F Zhou","year":"2018","unstructured":"Zhou, F., Shang, W., Yu, X. & Tian, J. Glypican-3: a promising biomarker for hepatocellular carcinoma diagnosis and treatment. Med. Res. Rev. 38, 741\u2013767 (2018).","journal-title":"Med. Res. Rev."},{"key":"3048_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang, J. D. et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat. Rev. Gastroenterol. Hepatol. 16, 589\u2013604 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"3048_CR5","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.dld.2018.08.019","volume":"50","author":"F De Stefano","year":"2018","unstructured":"De Stefano, F., Chacon, E., Turcios, L., Marti, F. & Gedaly, R. Novel biomarkers in hepatocellular carcinoma. Dig. Liver Dis. 50, 1115\u20131123 (2018).","journal-title":"Dig. Liver Dis."},{"key":"3048_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1159\/000499765","volume":"8","author":"L Rimassa","year":"2019","unstructured":"Rimassa, L., Pressiani, T. & Merle, P. Systemic treatment options in hepatocellular carcinoma. Liver Cancer 8, 427\u2013446 (2019).","journal-title":"Liver Cancer"},{"key":"3048_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"3048_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature25167","volume":"553","author":"M Milanovic","year":"2018","unstructured":"Milanovic, M. et al. Senescence-associated reprogramming promotes cancer stemness. Nature 553, 96\u2013100 (2018).","journal-title":"Nature"},{"key":"3048_CR9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1172\/JCI95148","volume":"128","author":"N Herranz","year":"2018","unstructured":"Herranz, N. & Gil, J. Mechanisms and functions of cellular senescence. J. Clin. Invest. 128, 1238\u20131246 (2018).","journal-title":"J. Clin. Invest."},{"key":"3048_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.08.006","volume":"19","author":"V Myrianthopoulos","year":"2019","unstructured":"Myrianthopoulos, V. et al. Senescence and senotherapeutics: a new field in cancer therapy. Pharm. Ther. 19, 31\u201349 (2019).","journal-title":"Pharm. Ther."},{"key":"3048_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41556-018-0249-2","volume":"21","author":"S Lee","year":"2019","unstructured":"Lee, S. & Schmitt, C. A. The dynamic nature of senescence in cancer. Nat. Cell Biol. 21, 94\u2013101 (2019).","journal-title":"Nat. Cell Biol."},{"key":"3048_CR12","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1152\/physrev.00020.2018","volume":"99","author":"A Calcinotto","year":"2019","unstructured":"Calcinotto, A. et al. Cellular senescence: aging, cancer, and injury. Physiol. Rev. 99, 1047\u20131078 (2019).","journal-title":"Physiol. Rev."},{"key":"3048_CR13","doi-asserted-by":"publisher","first-page":"e12942","DOI":"10.1111\/acel.12841","volume":"18","author":"M Ogrodnik","year":"2019","unstructured":"Ogrodnik, M., Salmonowicz, H. & Gladyshev, V. N. Integrating cellular senescence with the concept of damage accumulation in aging: Relevance for clearance of senescent cells. Aging Cell. 18, e12942 (2019).","journal-title":"Aging Cell."},{"key":"3048_CR14","doi-asserted-by":"publisher","first-page":"6893","DOI":"10.1021\/acs.chemrev.7b00775","volume":"118","author":"JL Counihan","year":"2018","unstructured":"Counihan, J. L., Grossman, E. A. & Nomura, D. K. Cancer metabolism: current understanding and therapies. Chem. Rev. 118, 6893\u20136923 (2018).","journal-title":"Chem. Rev."},{"key":"3048_CR15","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029\u20131033 (2009).","journal-title":"Science"},{"key":"3048_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10555-019-09794-5","volume":"38","author":"J Lu","year":"2019","unstructured":"Lu, J. The Warburg metabolism fuels tumor metastasis. Cancer Metastasis Rev. 38, 157\u2013164 (2019).","journal-title":"Cancer Metastasis Rev."},{"key":"3048_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41580-019-0123-5","volume":"20","author":"J Zhu","year":"2019","unstructured":"Zhu, J. & Thompson, C. B. Metabolic regulation of cell growth and proliferation. Nat. Rev. Mol. Cell Biol. 20, 436\u2013450 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3048_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova, N. N. & Thompson, C. B. The emerging hallmarks of cancer metabolism. Cell Metab. 23, 27\u201347 (2016).","journal-title":"Cell Metab."},{"key":"3048_CR19","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1182\/blood.2019001034","volume":"134","author":"Y Tabe","year":"2019","unstructured":"Tabe, Y., Lorenzi, P. L. & Konopleva, M. Amino acid metabolism in hematologic malignancies and the era of targeted therapy. Blood 134, 1014\u20131023 (2019).","journal-title":"Blood"},{"key":"3048_CR20","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2014-09-600643","volume":"125","author":"F Mussai","year":"2015","unstructured":"Mussai, F. et al. Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target. Blood 125, 2386\u20132396 (2015).","journal-title":"Blood"},{"key":"3048_CR21","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/ncb3272","volume":"17","author":"S Tardito","year":"2015","unstructured":"Tardito, S. et al. Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma. Nat. Cell Biol. 17, 1556\u20131568 (2015).","journal-title":"Nat. Cell Biol."},{"key":"3048_CR22","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41591-019-0423-5","volume":"25","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Methionine is a metabolic dependency of tumor-initiating cells. Nat. Med. 25, 825\u2013837 (2019).","journal-title":"Nat. Med."},{"key":"3048_CR23","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1074\/jbc.R114.607044","volume":"290","author":"MR Bauerle","year":"2015","unstructured":"Bauerle, M. R., Schwalm, E. L. & Booker, S. J. Mechanistic diversity of radical S-adenosylmethionine (SAM)-dependent methylation. J. Biol. Chem. 290, 3995\u20134002 (2015).","journal-title":"J. Biol. Chem."},{"key":"3048_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.ajhg.2015.09.013","volume":"97","author":"Y Kishita","year":"2015","unstructured":"Kishita, Y. et al. Intra-mitochondrial methylation deficiency due to mutations in SLC25A26. Am. J. Hum. Genet. 97, 761\u2013768 (2015).","journal-title":"Am. J. Hum. Genet."},{"key":"3048_CR25","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/febs.14028","volume":"284","author":"A Menga","year":"2017","unstructured":"Menga, A. et al. SLC25A26 overexpression impairs cell function via mtDNA hypermethylation and rewiring of methyl metabolism. FEBS J. 284, 967\u2013984 (2017).","journal-title":"FEBS J."},{"key":"3048_CR26","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1039\/C4SC00384E","volume":"5","author":"W Zhou","year":"2014","unstructured":"Zhou, W. et al. A mitochondrion-targeting copper complex exhibits potent cytotoxicity against cisplatin-resistant tumor cells through multiple mechanisms of action. Chem. Sci. 5, 2761 (2014).","journal-title":"Chem. Sci."},{"key":"3048_CR27","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1111\/jcmm.14971","volume":"24","author":"M Li","year":"2020","unstructured":"Li, M. et al. Novel mitochondrion-targeting copper (II) complex induces HK2 malfunction and inhibits glycolysis via Drp1-mediating mitophagy in HCC. J. Cell Mol. Med. 24, 3091\u20133107 (2020).","journal-title":"J. Cell Mol. Med."},{"key":"3048_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.freeradbiomed.2016.10.498","volume":"10","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z., Guo, M., Zhao, S., Shao, J. & Zheng, S. ROS-JNK1\/2-dependent activation of autophagy is required for the induction of anti-inflammatory effect of dihydroartemisinin in liver fibrosis. Free Radic. Biol. Med. 10, 272\u2013283 (2016).","journal-title":"Free Radic. Biol. Med."},{"key":"3048_CR29","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.bcp.2005.12.014","volume":"71","author":"V Pavillard","year":"2006","unstructured":"Pavillard, V., Nicolaou, A., Double, J. A. & Phillips, R. M. Methionine dependence of tumours: a biochemical strategy for optimizing paclitaxel chemosensitivity in vitro. Biochem. Pharmacol. 71, 772\u2013778 (2006).","journal-title":"Biochem. Pharmacol."},{"key":"3048_CR30","doi-asserted-by":"publisher","first-page":"6172","DOI":"10.1038\/s41388-019-0872-9","volume":"38","author":"X Yuan","year":"2019","unstructured":"Yuan, X., Larsson, C. & Xu, D. Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players. Oncogene 38, 6172\u20136183 (2019).","journal-title":"Oncogene"},{"key":"3048_CR31","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.3390\/ijms20133338","volume":"20","author":"X Yuan","year":"2019","unstructured":"Yuan, X. & Xu, D. Telomerase reverse transcriptase (TERT) in action: cross-talking with epigenetics. Int J. Mol. Sci. 20, 3338 (2019).","journal-title":"Int J. Mol. Sci."},{"key":"3048_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.gde.2020.02.001","volume":"60","author":"FK Lorbeer","year":"2020","unstructured":"Lorbeer, F. K. & Hockemeyer, D. TERT promoter mutations and telomeres during tumorigenesis. Curr. Opin. Genet. Dev. 60, 56\u201362 (2020).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"3048_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2018.07.013","volume":"43","author":"J Yu","year":"2018","unstructured":"Yu, J. et al. Telomerase reverse transcriptase regulates DNMT3B expression\/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma. Cancer Lett. 43, 33\u201341 (2018).","journal-title":"Cancer Lett."},{"key":"3048_CR34","first-page":"223","volume":"12","author":"DD Lee","year":"2019","unstructured":"Lee, D. D. et al. DNA hypermethylation within TERT promoter upregulates TERT expression in cancer. J. Clin. Invest. 12, 223\u2013229 (2019).","journal-title":"J. Clin. Invest."},{"key":"3048_CR35","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/srep16709","volume":"5","author":"T Tsujioka","year":"2015","unstructured":"Tsujioka, T. et al. Five-aza-2\u2019-deoxycytidine-induced hypomethylation of cholesterol 25-hydroxylase gene is responsible for cell death of myelodysplasia\/leukemia cells. Sci. Rep. 5, 709\u2013721 (2015).","journal-title":"Sci. Rep."},{"key":"3048_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0468-6","volume":"17","author":"J Shao","year":"2019","unstructured":"Shao, J. et al. TPP-related mitochondrial targeting copper (II) complex induces p53-dependent apoptosis in hepatoma cells through ROS-mediated activation of Drp1. Cell Commun. Signal. 17, 149 (2019).","journal-title":"Cell Commun. Signal."},{"key":"3048_CR37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.suronc.2017.01.009","volume":"26","author":"RA Burkhart","year":"2017","unstructured":"Burkhart, R. A., Ronnekleiv-Kelly, S. M. & Pawlik, T. M. Personalized therapy in hepatocellular carcinoma: molecular markers of prognosis and therapeutic response. Surg. Oncol. 26, 138\u2013145 (2017).","journal-title":"Surg. Oncol."},{"key":"3048_CR38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","volume":"16","author":"X Li","year":"2019","unstructured":"Li, X. et al. Navigating metabolic pathways to enhance anti-tumor immunity and immunotherapy. Nat. Rev. Clin. Oncol. 16, 425\u2013441 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"3048_CR39","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.15252\/embj.201696151","volume":"36","author":"J Zhang","year":"2017","unstructured":"Zhang, J., Pavlova, N. N. & Thompson, C. B. Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine. EMBO J. 36, 1302\u20131315 (2017).","journal-title":"EMBO J."},{"key":"3048_CR40","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","volume":"34","author":"CL Jones","year":"2018","unstructured":"Jones, C. L. et al. Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell 34, 724\u2013740 (2018).","journal-title":"Cancer Cell"},{"key":"3048_CR41","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1207\/s15327914nc5402_6","volume":"54","author":"D Komninou","year":"2006","unstructured":"Komninou, D., Leutzinger, Y., Reddy, B. S. & Richie, J. P. Jr. Methionine restriction inhibits colon carcinogenesis. Nutr. Cancer 54, 202\u2013208 (2006).","journal-title":"Nutr. Cancer"},{"key":"3048_CR42","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41568-019-0187-8","volume":"19","author":"SM Sanderson","year":"2019","unstructured":"Sanderson, S. M., Gao, X., Dai, Z. & Locasale, J. W. Methionine metabolism in health and cancer: a nexus of diet and precision medicine. Nat. Rev. Cancer 19, 625\u2013637 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"3048_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.gde.2020.02.003","volume":"60","author":"DD Lee","year":"2020","unstructured":"Lee, D. D., Komosa, M., Nunes, N. M. & Tabori, U. DNA methylation of the TERT promoter and its impact on human cancer. Curr. Opin. Genet. Dev. 60, 17\u201324 (2020).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"3048_CR44","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11060-018-03016-8","volume":"141","author":"Y Miyake","year":"2019","unstructured":"Miyake, Y. et al. TERT promoter methylation is significantly associated with TERT upregulation and disease progression in pituitary adenomas. J. Neurooncol. 141, 131\u2013138 (2019).","journal-title":"J. Neurooncol."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03048-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T15:26:24Z","timestamp":1670253984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03048-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,11]]},"references-count":44,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["3048"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-03048-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,11]]},"assertion":[{"value":"3 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"844"}}